Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin.
Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin.
复制标题
Interleukin-33 通过激活皮肤中的诱导型一氧化氮合酶来增强抗菌防御
DOI:
10.1371/journal.ppat.1003918
复制
发表时间:
2014-02
期刊:
影响因子:
6.7
通讯作者:
Lai Y
中科院分区:
文献类型:
--
作者:
Li C;Li H;Jiang Z;Zhang T;Wang Y;Li Z;Wu Y;Ji S;Xiao S;Ryffel B;Radek KA;Xia Z;Lai Y
Interleukin-33 (IL-33) is associated with multiple diseases, including asthma, rheumatoid arthritis, tissue injuries and infections. Although IL-33 has been indicated to be involved in Staphylococcus aureus (S. aureus) wound infection, little is known about how IL-33 is regulated as a mechanism to increase host defense against skin bacterial infections. To explore the underlying intricate mechanism we first evaluated the expression of IL-33 in skin from S. aureus-infected human patients. Compared to normal controls, IL-33 was abundantly increased in skin of S. aureus-infected patients. We next developed a S. aureus cutaneous infection mouse model and found that IL-33 was significantly increased in dermal macrophages of infected mouse skin. The expression of IL-33 by macrophages was induced by staphylococcal peptidoglycan (PGN) and lipoteichoic acid (LTA) via activation of toll-like receptor 2(TLR2) –mitogen-activated protein kinase (MAPK)-AKT-signal transducer and activator of transcription 3(STAT3) signaling pathway as PGN and LTA failed to induce IL-33 in Tlr2-deficient peritoneal macrophages, and MAPK,AKT, STAT3 inhibitors significantly decreased PGN- or LTA-induced IL-33. IL-33, in turn, acted on macrophages to induce microbicidal nitric oxygen (NO) release. This induction was dependent on inducible nitric oxide synthase (iNOS) activation, as treatment of macrophages with an inhibitor of iNOS, aminoguanidine, significantly decreased IL-33-induced NO release. Moreover, aminoguanidine significantly blocked the capacity of IL-33 to inhibit the growth of S. aureus, and IL-33 silencing in macrophages significantly increased the survival of S. aureus in macrophages. Furthermore, the administration of IL-33-neutralizing antibody into mouse skin decreased iNOS production but increased the survival of S. aureus in skin. These findings reveal that IL-33 can promote antimicrobial capacity of dermal macrophages, thus enhancing antimicrobial defense against skin bacterial infections.
登录
查看更多内容
DOI:
10.1073/pnas.0812690106
发表时间:
2009-06-02
影响因子:
11.1
作者:
Cayrol, Corinne;Girard, Jean-Philippe
通讯作者:
Girard, Jean-Philippe
DOI:
10.4049/jimmunol.1003020
发表时间:
2011-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kouzaki H;Iijima K;Kobayashi T;O'Grady SM;Kita H
通讯作者:
Kita H
影响因子:
32.4
作者:
Lai Y;Li D;Li C;Muehleisen B;Radek KA;Park HJ;Jiang Z;Li Z;Lei H;Quan Y;Zhang T;Wu Y;Kotol P;Morizane S;Hata TR;Iwatsuki K;Tang C;Gallo RL
通讯作者:
Gallo RL
影响因子:
2.9
作者:
Ghaffari, Abdi;Jalili, Reza;Ghahary, Aziz
通讯作者:
Ghahary, Aziz
影响因子:
4.4
作者:
Kurowska-Stolarska, Mariola;Kewin, Pete;Xu, Damo
通讯作者:
Xu, Damo